Search - tctmd.com

Displaying 141 - 160 of 333

Sort: Relevancy | Date

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

Podcast Heart Sounds

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Michael O'Riordan

June 14, 2017

News Industry News

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

May 25, 2017

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

L.A. McKeown

May 03, 2017

Presentation SIF 2017

OCT (Optical Coherence Tomography) A Must in Modern PCI

Presenter: Bimal B. Padiya

March 10, 2017

News Industry News

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

February 09, 2017

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Todd Neale

February 08, 2017

News Industry News

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

January 30, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Industry News

SoundBite Initiates Human Clinical Studies for Peripheral CTO Crossing Procedures

December 01, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

Los Beneficios del Ejercicio Físico No se Ven Afectados por la Historia Familiar de Cardiopatía

Yael L. Maxwell

September 08, 2016

News Daily News

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

Yael L. Maxwell

August 03, 2016

News Daily News

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Michael O'Riordan

July 27, 2016

News Daily News

Las Mujeres son Menos Propensas que los Hombres a Sobrevivir o a Recibir Tratamiento para Salvarles la Vida tras Sufrir una Parada Cardíaca

L.A. McKeown

June 24, 2016

Presentation CCVVC 2016

New technologies for the treatment of PAD: What’s happening outside the US?

Presenter: Jos C. van den Berg

June 15, 2016

Advertisement

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

Top Stories in Cardiology, June 2017

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

OCT (Optical Coherence Tomography) A Must in Modern PCI

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

SoundBite Initiates Human Clinical Studies for Peripheral CTO Crossing Procedures

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Los Beneficios del Ejercicio Físico No se Ven Afectados por la Historia Familiar de Cardiopatía

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Las Mujeres son Menos Propensas que los Hombres a Sobrevivir o a Recibir Tratamiento para Salvarles la Vida tras Sufrir una Parada Cardíaca

New technologies for the treatment of PAD: What’s happening outside the US?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content